Ikaros expression levels to predict response and survival following pomalidomide and dexamethasone in multiple myeloma (MM).
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8540-8540
10.1200/jco.2014.32.15_suppl.8540